Braze Inc (BRZE) PT Lowered to $41 at Stephens
Stephens analyst Brett Huff lowered the price target on Braze Inc (NASDAQ: BRZE) to $41.00 (from $51.00) while maintaining a Overweight rating.
The analyst commented: "Even w/a subs rev sequential deceleration + lower sequential NRR, we think growth resilience (+19% '26 guide) is remarkable given market's marketing spend variability worries. Think 1Q's pros > cons so remain OW w/updated estimates and target (from $51 to $41, based on 5.1x EV/FY2 rev, a 23% discount to 6.6x post-COVID average)."